However, further in vitro experiments, which were beyond the scope of the present translational study, will be needed in order to confirm the putative role of GLIS3 and ZNF658 in FNTB’s transcriptional regulation and its effects on oncogenic RAS signalling in breast cancer. The gene discussed is GLIS3; the disease is breast carcinoma.